Study identifier:D6256M00017
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
The use of a forecasting system for predicting exacerbations of COPD: effect on symptoms and hospitalisation and relevance of viral infections
Chronic obstructive pulmonary disease (COPD)
N/A
Yes
-
All
98
Interventional
40 Years +
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Verified 01 Nov 2010 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
Arms | Assigned Interventions |
---|---|
Experimental: Forecast COPD patients receiving advice and poor weather warning | Behavioral: COPD self care advice Information leaflets on COPD and thermometers to monitor the ambient temperature in the bedroom and living room Behavioral: Poor weather forecast warning Interactive automated telephone service to contact patients prior to anticipated periods of poor weather |
Experimental: No Forecast COPD patients receiving advice and poor weather warning | Behavioral: COPD self care advice Information leaflets on COPD and thermometers to monitor the ambient temperature in the bedroom and living room |
No Intervention: Control Age matched non - COPD subjects | - |